Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Weighted Average): 2014-2024

Historic Shares Outstanding (Weighted Average) for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Dec 2024 value amounting to $48.1 million.

  • Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) fell 4.48% to $46.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.5 million, marking a year-over-year decrease of 4.48%. This contributed to the annual value of $48.1 million for FY2024, which is 0.36% up from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Shares Outstanding (Weighted Average) of $48.1 million as of FY2024, which was up 0.36% from $47.9 million recorded in FY2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) peaked at $48.3 million during FY2022, and registered a low of $47.5 million during FY2020.
  • For the 3-year period, Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) averaged around $48.1 million, with its median value being $48.1 million (2024).
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) climbed by 1.21% in 2020 and then dropped by 0.88% in 2023.
  • Amphastar Pharmaceuticals' Shares Outstanding (Weighted Average) (Yearly) stood at $47.5 million in 2020, then climbed by 0.73% to $47.8 million in 2021, then increased by 1.01% to $48.3 million in 2022, then dropped by 0.88% to $47.9 million in 2023, then rose by 0.36% to $48.1 million in 2024.